Rodriguez 1997.

Methods	The cross‐over trial is a CCT but it is not clear whether the method of randomisation was adequate.
Participants	25 Children with the average age of 9.76 years old (6 to 12 years) with primary dyslipidaemia and excluded people with secondary dyslipidaemia.
Interventions	Oral carnitine (1g (10cc), 3 times a day) (Group A) versus placebo (Group B) for 8 weeks, at which point the participants had a 15 days washout period and another 8 weeks of treatment: oral carnine (Group B) versus placebo (Group A).
Outcomes	Biochemical variables (serum LDL, total cholesterol, cholestrol‐HDL, glycaemia, uric acid, creatinine, triglycerides, hemoglobin, level of plasma carnitine). Anthropometric variables (weight, height, body mass index (BMI), measures of circumferences waist/thigh, the cutaneous pleats (sub scapular, brachial pleat)). Changes in eating behaviour, treatment tolerances (patient satisfaction).
Notes	The number of participants allocated in each group and some methodological details are not clear. We have contacted the trialists but have not yet received a response.

BMI: body mass index
 CCT: controlled clinical trial
 HDL: high‐density lipoprotein
 LDL: low‐density lipoprotein